Parplus Partners’s CME Group CME Stock Holding History

Parplus Partners’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,358	Closed	-$473K	–	39
2019 Q4	$473K	Buy	+2,358	New	+$484K	0.09%	67

Other funds holding CME

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Parplus Partners's CME Position: Q1 2020 in Review

Parplus Partners sold out of CME Group (CME) in Q1 2020, closing a stake of 2,358 shares — an estimated $473K sold.

Parplus Partners first reported a position in CME in Q4 2019 and held it in 1 quarter. The position peaked at $473K in Q4 2019. 1,029 funds tracked by Wall St. Rank hold CME as of Q1 2020.

Parplus Partners reported no remaining CME Group position as of Q1 2020 after selling out during the quarter.
Parplus Partners sold 2,358 CME Group shares in Q1 2020, an estimated $473K.
Parplus Partners first reported a position in CME Group in Q4 2019 and held it in 1 quarter.
Parplus Partners's CME Group position peaked at $473K in Q4 2019.
1,029 funds tracked by Wall St. Rank held CME Group as of Q1 2020.

Based on Parplus Partners's 13F filing for Q1 2020, filed 14 May 2020.